Bank of New York Mellon
ZY

Bank of New York Mellon’s Zymergen Inc. Common Stock ZY Stock Holding History

Bank of New York Mellon’s Portfolio ZY Stock Details ZY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-33,346
Closed -$93K – 4622
2022
Q3 		$93K Buy
+33,346
New +$80.9K ﹤0.01% 4212
2022
Q2 		– Sell
-222,863
Closed -$644K – 4749
2022
Q1 		$644K Sell
222,863
-969
-0.4% -$4.12K ﹤0.01% 3564
2021
Q4 		$1.5M Buy
223,832
+158,027
+240% +$1.53M ﹤0.01% 3155
2021
Q3 		$867K Buy
65,805
+6,354
+11% +$135K ﹤0.01% 3472
2021
Q2 		$2.38M Buy
+59,451
New +$2.35M ﹤0.01% 2880

Bank of New York Mellon's ZY Position: Q4 2022 in Review

Bank of New York Mellon sold out of Zymergen Inc. Common Stock (ZY) in Q4 2022, closing a stake of 33,346 shares — an estimated $93K sold.

Bank of New York Mellon first reported a position in ZY in Q2 2021 and held it in 5 quarters. The position peaked at $2.38M in Q2 2021. 0 funds tracked by Wall St. Rank hold ZY as of Q4 2022.

  • Bank of New York Mellon reported no remaining Zymergen Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
  • Bank of New York Mellon sold 33,346 Zymergen Inc. Common Stock shares in Q4 2022, an estimated $93K.
  • Bank of New York Mellon first reported a position in Zymergen Inc. Common Stock in Q2 2021 and held it in 5 quarters.
  • Bank of New York Mellon's Zymergen Inc. Common Stock position peaked at $2.38M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Zymergen Inc. Common Stock as of Q4 2022.

Based on Bank of New York Mellon's 13F filing for Q4 2022, filed 14 Feb 2023.